Dr. Reddy’s intros Prometrium generic

David Salazar

4/24/2017

HYDERABAD, India and PRINCETON, N.J. — Dr. Reddy’s Laboratories on Friday announced the U.S. launch of its generic of AbbVie’s Prometrium (progesterone) capsules.

The Dr. Reddy’s progesterone capsules — recently approved by the Food and Drug Administration — will be available in 100- and 200-mg dosage strengths. According to QuintilesIMS data, brand and generic sales for the product had U.S. moving annual total sales of $153 million for the 12 months ended February 2017.

The capsules will be available in 100-count bottles.

Walgreens buyout reportedly could result in three divisions

Walgreens’ three core segments—U.S. pharmacy retailer Walgreens, U.K.-based Boots and specialty unit Shields Health Solutions—could become three independent divisions, per a report.

Sycamore Partners reportedly working on financing to acquire Walgreens

A potential buyout reportedly would include terms loans, a bridge loan and asset-based lending.

Ulta Beauty sets date for experiential beauty event

Ulta Beauty World will take place on April 26 in San Antonio, Texas.

Walgreens reportedly close to roughly $10B deal to go private

The deal could be finalized by Thursday, per a WSJ report.

CVS Health to open smaller format stores

Each location will average less than 5,000 square feet and will feature a full-service pharmacy with limited over-the-counter products available for purchase.